Incremental Prognostic Value of Right Ventricular–Pulmonary Artery Coupling to a Clinical Risk Score in Tricuspid Regurgitation: The TRIO-RV Score - 03/03/25
Abstract |
Objectives |
There are limited data evaluating the echocardiographic parameters of risk in tricuspid regurgitation (TR) patients. We sought to evaluate the incremental prognostic value of quantitative right ventricle (RV) function and RV–pulmonary artery (RV-PA) coupling to an established clinical risk score in TR patients.
Methods |
We retrospectively identified patients with moderate or greater TR from January 1, 2019, to June 30, 2019. Univariable and multivariable Cox proportional hazards regressions were used to test the association of right ventricular free wall strain (RVFWS), RVFWS indexed to right ventricular systolic pressure (RVSP), and the Tricuspid Regurgitation Impact on Outcomes (TRIO) risk score with mortality. A novel TRIO-RV risk score was developed by incorporating RVFWS/RVSP into the clinical TRIO risk score.
Results |
Among 417 patients, age 73 ± 11.5 years, 47% female, the TRIO score was 3.5 ± 2. The TRIO score was low risk in 213 (51%), intermediate risk in 162 (39%), and high risk in 42 (10%). During a median follow-up of 3.96 years (interquartile range, 1.66-4.34 years), death occurred in 157 patients (38%). The baseline TRIO risk category was associated with mortality (P < .001). After adjustment by TRIO risk score, both RVFWS <18.6% (adjusted hazard ratio, 3.08; 95% CI, 2.01-4.72; P < .001) and RVFWS/RVSP <0.43 %/mm Hg (adjusted hazard ratio, 2.76; 95% CI, 1.75-4.35, P < .001) remained significantly correlated with mortality. With the addition of RVFWS/RVSP, 151 (40%) patients with low- and intermediate-risk TRIO scores were reclassified to a higher-risk TRIO-RV score. The chi-square value increased in sequential models predictive of mortality for the TRIO score alone, the TRIO score plus RVFWS <18.6%, and the TRIO score plus RVFWS/RVSP <0.43 %/mm Hg (model chi-square 38.3, 72.2, and 82.3, respectively).
Conclusions |
Quantitative parameters of RV function are associated with mortality in TR patients even after correction for an existing clinical risk score. Incorporating RVFWS/RVSP into the TRIO clinical risk score, the TRIO-RV score, reclassifies a substantial number of low- and intermediate-risk patients into higher-risk categories and improves risk stratification.
Le texte complet de cet article est disponible en PDF.Highlights |
• | RVFWS/RVSP is an independent correlate of mortality in TR patients. |
• | TR patients with an RVFWS/RVSP <0.43 %/mm Hg have a 2- to 3-fold increase in mortality. |
• | Adding RVFWS/RVSP reclassifies 40% of low-/intermediate-risk TRIO patients to higher risk. |
Keywords : Tricuspid regurgitation, Right ventricular to pulmonary artery coupling, Right ventricular free wall strain, Right ventricular systolic pressure
Abbreviations : AF, AST, AUC, CHF, FAC, HR, LVEF, PA, RV, RVFWS, RVSP, TAPSE, TR, TRIO
Plan
| Muhamed Saric, MD, served as guest editor for this report. |
Vol 38 - N° 3
P. 239-246 - mars 2025 Retour au numéro
Article précédent
- Are New Thresholds Required for the Assessment of Right Ventricular Function in Patients With and Without Tricuspid Regurgitation?
- Xavier Galloo, Nina Ajmone Marsan
- The Right Ventricle and Exercise Capacity in Adults with Repaired Tetralogy of Fallot: Passive Bystander or Active Participant?
- Zachary Barrett-O’Keefe, Chera L. Maarouf, Jessica A. Narum, Timothy J. Fuller, James M. Welper, William R. Miranda, C. Charles Jain, Heidi M. Connolly, Luke J. Burchill, Alexander C. Egbe
Bienvenue sur EM-consulte, la référence des professionnels de santé.
L’accès au texte intégral de cet article nécessite un abonnement.
Déjà abonné à cette revue ?